Distribution of HPV Genotypes in Cervical Cancers in India and correlation with the PreTect HPV Proofer E6/E7 mRNA Test - Bengaluru, Delhi, Guwahati, Kolkata, Nagpur

HPV E6/E7 Oncogene mRNA testing can more accurately detect women with persistent transforming HPV infection, which is more likely to lead to cervical cancer. This will improve the specificity and prognostic value of HPV testing, with higher sensitivity than L1-based HPV DNA tests. Additionally, the study is expected to provide a more accurate picture of the prevalence pattern of HPV types in invasive cancers in India.

Target population:

Cervical Cancer patients.

Supported
by:

Memorial University, St. John’s, Canada.

Period:

2007 – 2008.

Investigator:

Maqsood Siddiqi.